Clinical trial
Tenofovir Adherence to Rapidly Guide and Evaluate PrEP and HIV Therapy
NCT03012607 · University of Washington, Other · Completed
Key facts
| NCT number | NCT03012607 |
|---|---|
| Title | Tenofovir Adherence to Rapidly Guide and Evaluate PrEP and HIV Therapy |
| Official title | Pharmacokinetics of Tenofovir in Blood, Plasma and Urine of Healthy Adults With Perfect, Median and Low Drug Adherence |
| Acronym | TARGET |
| Lead sponsor | University of Washington, Other |
| Collaborators | Chiang Mai University National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hiv |
| Intervention type | Drug |
| Interventions | Truvada |
| Enrollment | 30 |
| Start date | Jan 1, 2017 |
| Primary completion | Mar 1, 2018 |
| Completion | Mar 1, 2018 |
| First posted | Jan 6, 2017 |
| Last update posted | Feb 7, 2020 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: